Colleen Timlin

898 total citations
14 papers, 99 citations indexed

About

Colleen Timlin is a scholar working on Hematology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Colleen Timlin has authored 14 papers receiving a total of 99 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Colleen Timlin's work include Hematopoietic Stem Cell Transplantation (8 papers), Acute Lymphoblastic Leukemia research (4 papers) and Neutropenia and Cancer Infections (3 papers). Colleen Timlin is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Acute Lymphoblastic Leukemia research (4 papers) and Neutropenia and Cancer Infections (3 papers). Colleen Timlin collaborates with scholars based in United States. Colleen Timlin's co-authors include Alex Ganetsky, Alison W. Loren, Mary Ellen Martin, James K. Mangan, Selina M. Luger, Elizabeth O. Hexner, Noelle V. Frey, Saar Gill, Terri Lynn Shigle and Ryan Shaw and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Bone Marrow Transplantation.

In The Last Decade

Colleen Timlin

14 papers receiving 97 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colleen Timlin United States 5 49 24 22 16 15 14 99
Agnès Bonnin France 6 65 1.3× 22 0.9× 53 2.4× 15 0.9× 13 0.9× 19 126
Milena Kohn France 5 42 0.9× 31 1.3× 26 1.2× 8 0.5× 14 0.9× 9 81
Melisa Stricherz United States 3 38 0.8× 19 0.8× 27 1.2× 13 0.8× 20 1.3× 7 104
Aly Abdel‐Mageed United States 5 38 0.8× 37 1.5× 16 0.7× 7 0.4× 23 1.5× 7 97
Cathryn Jennissen United States 5 57 1.2× 11 0.5× 15 0.7× 17 1.1× 29 1.9× 7 94
Maxi Wass Germany 4 30 0.6× 12 0.5× 24 1.1× 8 0.5× 13 0.9× 7 74
J. Allyson Hays United States 3 57 1.2× 36 1.5× 10 0.5× 9 0.6× 12 0.8× 4 82
Tounes Ledraa France 6 92 1.9× 31 1.3× 58 2.6× 11 0.7× 17 1.1× 12 120
Karine Augeul-Meunier France 7 37 0.8× 24 1.0× 46 2.1× 8 0.5× 7 0.5× 13 108
Steffie van der Werf Netherlands 8 72 1.5× 28 1.2× 60 2.7× 33 2.1× 11 0.7× 15 178

Countries citing papers authored by Colleen Timlin

Since Specialization
Citations

This map shows the geographic impact of Colleen Timlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colleen Timlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colleen Timlin more than expected).

Fields of papers citing papers by Colleen Timlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colleen Timlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colleen Timlin. The network helps show where Colleen Timlin may publish in the future.

Co-authorship network of co-authors of Colleen Timlin

This figure shows the co-authorship network connecting the top 25 collaborators of Colleen Timlin. A scholar is included among the top collaborators of Colleen Timlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colleen Timlin. Colleen Timlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Loren, Alison W., Elizabeth O. Hexner, Mary Ellen Martin, et al.. (2022). Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies. Transplantation and Cellular Therapy. 29(2). 113–118. 2 indexed citations
2.
3.
Freyer, Craig W., Shannon Gier, Alex Ganetsky, et al.. (2021). Leucovorin Rescue After Methotrexate Graft-Versus-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment, and Hospital Length of Stay. Transplantation and Cellular Therapy. 27(5). 431.e1–431.e8. 2 indexed citations
4.
Martin, Mary Ellen, Jessica C. Smith, Shannon R. McCurdy, et al.. (2021). Incidence and Predictors of Sars-Cov-2 Antibody Responses Following COVID-19 Vaccination in Allogeneic Stem Cell Transplant Recipients. Blood. 138(Supplement 1). 2888–2888. 1 indexed citations
5.
6.
Freyer, Craig W., Alex Ganetsky, Mitchell E. Hughes, et al.. (2020). Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation. Leukemia & lymphoma. 61(9). 2200–2207. 5 indexed citations
7.
Freyer, Craig W., Alex Ganetsky, Colleen Timlin, et al.. (2019). Leucovorin Following Methotrexate Graft-Vs-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment and Length of Hospitalization in Myeloablative Allogeneic Hematopoietic Transplantation. Biology of Blood and Marrow Transplantation. 25(3). S283–S283. 2 indexed citations
8.
Bange, Erin M., et al.. (2018). Evidence for and Against Green Tea and Turmeric in the Management of Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 18(10). e421–e426. 11 indexed citations
9.
Ganetsky, Alex, Noelle V. Frey, Elizabeth O. Hexner, et al.. (2018). Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract. Bone Marrow Transplantation. 54(2). 212–217. 33 indexed citations
10.
Freyer, Craig W., Alex Ganetsky, Mitchell E. Hughes, et al.. (2018). Venous Thromboembolism Following Pegaspargase in Adults Receiving Antithrombin Supplementation: A Single Center Characterization of Risk Factors and an Assessment of Supplementation Practice. Blood. 132(Supplement 1). 4023–4023. 2 indexed citations
11.
Freyer, Craig W., Alex Ganetsky, Colleen Timlin, et al.. (2018). Leucovorin Following Methotrexate Graft-Vs-Host Disease Prophylaxis in Myeloablative Allogeneic Hematopoietic Transplantation Shortens the Duration of Mucositis and Hospitalization. Blood. 132(Supplement 1). 5696–5696. 2 indexed citations
12.
Ganetsky, Alex, Noelle V. Frey, Alison W. Loren, et al.. (2016). Tocilizumab Is Highly Active for Severe Steroid-Refractory Acute Graft-Versus-Host Disease of the Gastrointestinal Tract. Blood. 128(22). 2245–2245. 3 indexed citations
13.
Timlin, Colleen, Rahul Banerjee, Christina Howlett, et al.. (2016). Comparable outcomes in CLL patients treated with reduced-dose ibrutinib: Results from a multi-center study.. Journal of Clinical Oncology. 34(15_suppl). 7529–7529. 1 indexed citations
14.
Timlin, Colleen, et al.. (2015). A Comparison of Single Dose Rasburicase 3 Mg Versus 6 Mg for the Management of Tumor Lysis Syndrome. Blood. 126(23). 4511–4511. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agnès Bonnin Breakdown of academic impact, for papers by Milena Kohn Breakdown of academic impact, for papers by Melisa Stricherz Breakdown of academic impact, for papers by Aly Abdel‐Mageed Breakdown of academic impact, for papers by Cathryn Jennissen Breakdown of academic impact, for papers by Maxi Wass Breakdown of academic impact, for papers by J. Allyson Hays Breakdown of academic impact, for papers by Tounes Ledraa Breakdown of academic impact, for papers by Karine Augeul-Meunier Breakdown of academic impact, for papers by Steffie van der Werf
Rankless by CCL
2026